Physician profile
Parth U Patel
NPI 1669762365
$48,325.91
in general payments reported to CMS, 2019-2025
20 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,567 · 2020: $9,167 · 2021: $13K · 2022: $12K · 2023: $6,830 · 2024: $767 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Food and Beverage: $1,305 · Travel and Lodging: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Food and Beverage | $1,305.28 |
| Travel and Lodging | $1,037.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $45,956.42 | 2019-2024 | Da Vinci Surgical System, Da Vinci Sp |
| Endogastric Solutions, INC | $825.41 | 2020-2024 | Esophyx |
| Tela Bio, INC. | $778.80 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Pacira Pharmaceuticals Incorporated | $127.82 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2024 | |
| Abbott Laboratories | $98.90 | 2025 | Navitor |
| Medtronic, INC. | $87.91 | 2022 | |
| Enterra Medical, INC. | $56.97 | 2023-2024 | |
| Lucid Diagnostics INC. | $46.15 | 2023 | |
| Integra Lifesciences Corporation | $32.83 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tei Biosciences INC | $29.00 | 2019 | |
| Bard Peripheral Vascular, INC. | $24.87 | 2020 | |
| Cook Medical LLC | $20.87 | 2022 | |
| Allergan, INC. | $19.19 | 2019 | |
| Organogenesis INC. | $18.55 | 2025 | Novachor |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $17.20 | 2019 | |
| Innocoll Pharmaceuticals Limited | $16.93 | 2022 | |
| Abbvie INC. | $16.15 | 2021 | |
| Portola Pharmaceuticals, LLC | $13.94 | 2019 | |
| Davol INC. | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parth Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.